GSK1349572
Phase 1Completed 0 watching 0 views this week💤 Quiet
33
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Infection, Human Immunodeficiency Virus
Conditions
Infection, Human Immunodeficiency Virus, HIV Infections
Trial Timeline
Feb 15, 2010 → Apr 5, 2010
NCT ID
NCT01068925About GSK1349572
GSK1349572 is a phase 1 stage product being developed by Shionogi for Infection, Human Immunodeficiency Virus. The current trial status is completed. This product is registered under clinical trial identifier NCT01068925. Target conditions include Infection, Human Immunodeficiency Virus, HIV Infections.
Hype Score Breakdown
Clinical
10
Activity
5
Company
10
Novelty
3
Community
2
Clinical Trials (4)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01332565 | Phase 1 | Completed |
| NCT01231529 | Phase 1 | Completed |
| NCT01068925 | Phase 1 | Completed |
| NCT00774111 | Phase 1 | Completed |
Competing Products
20 competing products in Infection, Human Immunodeficiency Virus